» Articles » PMID: 38076327

CD146-targeted Nuclear Medicine Imaging in Cancer: State of the Art

Overview
Journal View (Beijing)
Date 2023 Dec 11
PMID 38076327
Authors
Affiliations
Soon will be listed here.
Abstract

The transmembrane glycoprotein adhesion molecule CD146 is overexpressed in a wide variety of cancers. Through molecular imaging, a specific biomarker's expression and distribution can be viewed non-invasively. Radionuclide-labeled monoclonal antibodies or relevant fragments that target CD146 may find potential applications in cancer imaging, thereby offering tremendous value in cancer diagnosis, staging, prognosis evaluation, and prediction of drug resistance. This review discusses the recent developments of CD146-targeted molecular imaging via nuclear medicine, especially in malignant melanoma, brain tumor, lung cancer, liver cancer, breast cancer, and pancreatic cancer. Many studies have proved that CD146 targeting may present a promising strategy for cancer theranostics.

Citing Articles

Antigen targeting and anti-tumor activity of a novel anti-CD146 Pb internalizing alpha-radioimmunoconjugate against malignant peritoneal mesothelioma.

Lindland K, Malenge M, Li R, Wouters R, Bonsdorff T, Juzeniene A Sci Rep. 2024; 14(1):25941.

PMID: 39472474 PMC: 11522520. DOI: 10.1038/s41598-024-76778-z.


3D‑printed template‑guided iodine‑125 seed implantation to treat complete occlusion of the superior vena cava in pulmonary sarcomatoid carcinoma: A case report.

Di X, Yu H, Gao Z, Zhao J, Liu X, Liang Y Oncol Lett. 2024; 28(6):555.

PMID: 39355787 PMC: 11443305. DOI: 10.3892/ol.2024.14687.


overexpression inhibits colorectal cancer cell migration through the regulation of epithelial‑mesenchymal transition.

Wanna-Udom S, Aluksanasuwan S, Somsuan K, Mongkolwat W, Sakulsak N Mol Med Rep. 2024; 30(5).

PMID: 39301629 PMC: 11406482. DOI: 10.3892/mmr.2024.13325.


Pesticide residue detection technology for herbal medicine: current status, challenges, and prospects.

Peng B, Xie Y, Lai Q, Liu W, Ye X, Yin L Anal Sci. 2024; 40(4):581-597.

PMID: 38367162 DOI: 10.1007/s44211-024-00515-9.

References
1.
Melnikova V, Balasubramanian K, Villares G, Dobroff A, Zigler M, Wang H . Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. J Biol Chem. 2009; 284(42):28845-55. PMC: 2781430. DOI: 10.1074/jbc.M109.042150. View

2.
Zigler M, Villares G, Dobroff A, Wang H, Huang L, Braeuer R . Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. Cancer Res. 2011; 71(10):3494-504. PMC: 3096710. DOI: 10.1158/0008-5472.CAN-10-3555. View

3.
Qiao Y, Qian Y, Wang J, Tang X . Melanoma cell adhesion molecule stimulates yes-associated protein transcription by enhancing CREB activity via c-Jun/c-Fos in hepatocellular carcinoma cells. Oncol Lett. 2016; 11(6):3702-3708. PMC: 4887844. DOI: 10.3892/ol.2016.4442. View

4.
Wu G . Enforced Expression of METCAM/MUC18 Decreases In Vitro Motility and Invasiveness and Tumorigenesis and In Vivo Tumorigenesis of Human Ovarian Cancer BG-1 Cells. Adv Exp Med Biol. 2021; 1330:125-137. DOI: 10.1007/978-3-030-73359-9_8. View

5.
Sun H, England C, Hernandez R, Graves S, Majewski R, Kamkaew A . ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer. Eur J Nucl Med Mol Imaging. 2016; 43(12):2169-2179. PMC: 5050101. DOI: 10.1007/s00259-016-3442-1. View